Follow
Camilo Barbosa
Camilo Barbosa
Infectious diseases at University of Michigan
Verified email at umich.edu
Title
Cited by
Cited by
Year
Alternative evolutionary paths to bacterial antibiotic resistance cause distinct collateral effects
C Barbosa, V Trebosc, C Kemmer, P Rosenstiel, R Beardmore, ...
Molecular biology and evolution 34 (9), 2229-2244, 2017
1112017
Antibiotic combination efficacy (ACE) networks for a Pseudomonas aeruginosa model
C Barbosa, R Beardmore, H Schulenburg, G Jansen
PLoS biology 16 (4), e2004356, 2018
602018
Temporal variation in antibiotic environments slows down resistance evolution in pathogenic Pseudomonas aeruginosa
R Roemhild, C Barbosa, RE Beardmore, G Jansen, H Schulenburg
Evolutionary applications 8 (10), 945-955, 2015
572015
Experimental evolution as an efficient tool to dissect adaptive paths to antibiotic resistance
G Jansen, C Barbosa, H Schulenburg
Drug Resistance Updates 16 (6), 96-107, 2013
542013
Travelling at a slug’s pace: possible invertebrate vectors of Caenorhabditis nematodes
C Petersen, RJ Hermann, MC Barg, R Schalkowski, P Dirksen, C Barbosa, ...
BMC ecology 15 (1), 1-13, 2015
472015
Evolutionary stability of collateral sensitivity to antibiotics in the model pathogen Pseudomonas aeruginosa
C Barbosa, R Römhild, P Rosenstiel, H Schulenburg
eLife, 2019
412019
Association between clinical antibiotic resistance and susceptibility of Pseudomonas in the cystic fibrosis lung
G Jansen, N Mahrt, L Tueffers, C Barbosa, M Harjes, G Adolph, ...
Evolution, medicine, and public health 2016 (1), 182-194, 2016
412016
Ten years of life in compost: temporal and spatial variation of North German Caenorhabditis elegans populations
C Petersen, M Saebelfeld, C Barbosa, B Pees, RJ Hermann, ...
Ecology and evolution 5 (16), 3250-3263, 2015
282015
Co-evolutionary dynamics of the bacteria Vibrio sp. CV1 and phages V1G, V1P1, and V1P2: implications for phage therapy
C Barbosa, P Venail, AV Holguin, MJ Vives
Microbial ecology 66 (4), 897-905, 2013
272013
Enhanced behavioral immune defenses in a C. elegans C-type lectin-like domain gene mutant
B Pees, A Kloock, R Nakad, C Barbosa, K Dierking
Developmental & Comparative Immunology 74, 237-242, 2017
232017
Pseudomonas aeruginosa populations in the cystic fibrosis lung lose susceptibility to newly applied β-lactams within 3 days
L Tueffers, C Barbosa, I Bobis, S Schubert, M Höppner, M Rühlemann, ...
Journal of Antimicrobial Chemotherapy 74 (10), 2916-2925, 2019
172019
Bottleneck size and selection level reproducibly impact evolution of antibiotic resistance
N Mahrt, A Tietze, S Künzel, S Franzenburg, C Barbosa, G Jansen, ...
Nature ecology & evolution 5 (9), 1233-1242, 2021
142021
The Genomic Basis of Rapid Adaptation to Antibiotic Combination Therapy in Pseudomonas aeruginosa
C Barbosa, N Mahrt, J Bunk, M Graßer, P Rosenstiel, G Jansen, ...
Molecular biology and evolution 38 (2), 449-464, 2021
132021
Why is preventing antibiotic resistance so hard? Analysis of failed resistance management
S Zhou, C Barbosa, RJ Woods
Evolution, Medicine, and Public Health 2020 (1), 102-108, 2020
52020
Variants in ampD and dacB lead to in vivo resistance evolution of Pseudomonas aeruginosa within the central nervous system
C Barbosa, KS Gregg, RJ Woods
Journal of Antimicrobial Chemotherapy 75 (11), 3405-3408, 2020
22020
Genetic determinants of antibiotic resistance and the evolution of trade-offs during adaptation in a single patient
RJ Woods, C Barbosa, L Koepping, JAR Garay, M Mwangi, AF Read
bioRxiv, 2021
2021
Evolutionary Roads to Antibiotic Resistance in Pseudomonas Aeruginosa
C Barbosa
University of Kiel, 2017
2017
Travelling at a slug’s pace: possible invertebrate vectors of Caenorhabditis nematodes
H Schulenburg, C Barbosa, P Dirksen, R Schalkowski, MC Barg, ...
2015
The system can't perform the operation now. Try again later.
Articles 1–18